Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
eFFECTOR Therapeutics (EFTR)
OTHER OTC:EFTR
Holding EFTR?
Track your performance easily
EFTR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.03 - $17.75
Previous CloseN/A
Volume10.00
Average Volume (3M)9.45K
Market Cap
$5.00
Enterprise ValueN/A
Total Cash (Recent Filing)$15.22M
Total Debt (Recent Filing)$6.95M
Price to Earnings (P/E)―
Beta-0.35
Next Earnings
Mar 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.31
Shares Outstanding4,704,409
10 Day Avg. Volume2,850
30 Day Avg. Volume9,448
Standard Deviation0.34
R-Squared0.00583
Alpha-0.14
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
eFFECTOR Therapeutics News
PremiumCompany Announcements
eFFECTOR Therapeutics Initiates Wind-Down and Leadership Change
Ownership Overview
5.43% Insiders
<0.01% Mutual Funds
1.31% Other Institutional Investors
93.25% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
EFTR FAQ
What was eFFECTOR Therapeutics’s price range in the past 12 months?
eFFECTOR Therapeutics lowest stock price was $0.03 and its highest was $17.75 in the past 12 months.
What is eFFECTOR Therapeutics’s market cap?
eFFECTOR Therapeutics’s market cap is $5.00.
When is eFFECTOR Therapeutics’s upcoming earnings report date?
eFFECTOR Therapeutics’s upcoming earnings report date is Mar 12, 2025 which is in 40 days.
How were eFFECTOR Therapeutics’s earnings last quarter?
Currently, no data Available
Is eFFECTOR Therapeutics overvalued?
According to Wall Street analysts eFFECTOR Therapeutics’s price is currently Overvalued.
Does eFFECTOR Therapeutics pay dividends?
eFFECTOR Therapeutics does not currently pay dividends.
What is eFFECTOR Therapeutics’s EPS estimate?
eFFECTOR Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does eFFECTOR Therapeutics have?
eFFECTOR Therapeutics has 4,704,409 shares outstanding.
What happened to eFFECTOR Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of eFFECTOR Therapeutics?
Currently, no hedge funds are holding shares in EFTR
---
Company Description
eFFECTOR Therapeutics
Locust Walk Acquisition Corp is a blank check company.
---
EFTR Stock 12 Month Forecast
Average Price Target
―Fate Therapeutics
―
Karyopharm Therapeutics
―
Arcutis Biotherapeutics
―
Immatics
―
Foghorn Therapeutics
―
Best Analysts Covering EFTR
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-80.00%
reiterated a buy rating 10 months ago
Copying Benjamin Burnett's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -80.00% per trade.
---